Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Primary antibodies

Anti-Parkin Recombinant Antibody (N136/16) (HT315013)

Anti-Parkin Recombinant Antibody (N136/16)
Anti-Parkin Recombinant Antibody (N136/16)
Anti-Parkin Recombinant Antibody (N136/16)
Anti-Parkin Recombinant Antibody (N136/16)
Price(USD):
Spec:
  • 20ug
  • 50ug
  • 100ug
  • 1mg
Number:
Get quote
  • Overview

  • Images

  • References

  • Datasheet

  • SDS

Overview
Catalog No.HT315013
Species reactivityMouse
ApplicationsIHC, WB, IF
Host speciesMouse
IsotypeIgG2a, kappa
Clone IDN136/16
Clonality Monoclonal
Target Parkin, PARK2, Parkinson juvenile disease protein 2, E3 ubiquitin-protein ligase parkin, Parkin RBR E3 ubiquitin-protein ligase, PRKN, Parkinson disease protein 2
Endotoxin level Please contact with the lab for this information.
Purity >95% as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession Q9WVS6
RRID

Anti-Parkin Antibody (N136/16) (abinScience Cat# HT315013, RRID:AB_3728020)
_x005F_x000D_

Form Liquid
Storage buffer 0.01M PBS pH 7.4

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Product Usage Information
Application Dilution
WB 1:500-1:2000
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Background

E3 ubiquitin-protein ligase parkin (PRKN) is a ~51 kDa protein. Functions within a multiprotein E3 ubiquitin ligase complex, catalyzing the covalent attachment of ubiquitin moieties onto substrate proteins. Substrates include SYT11 and VDAC1. Other substrates are BCL2, CCNE1, GPR37, RHOT1/MIRO1, MFN1, MFN2, STUB1, SNCAIP, SEPTIN5, TOMM20, USP30, ZNF746, MIRO1 and AIMP2. Mediates monoubiquitination as well as 'Lys-6', 'Lys-11', 'Lys-48'-linked and 'Lys-63'-linked polyubiquitination of substrates depending on the context. Participates in the removal and/or detoxification of abnormally folded or damaged protein by mediating 'Lys-63'-linked polyubiquitination of misfolded proteins such as PARK7: 'Lys-63'-linked polyubiquitinated misfolded proteins are then recognized by HDAC6, leading to their recruitment to aggresomes, followed by degradation.

1. Wang, C. et al. (2018) Nature communications 9, 81. PMID: 29311685
2. Ham, SJ. et al. (2020) Proceedings of the National Academy of Sciences of the United States of America 117, 4281-4291. PMID: 32047033
3. Shiba-Fukushima, K. et al. (2014) PLoS genetics 10, e1004861. PMID: 25474007
4. Kuroda, Y. et al. (2012) Human molecular genetics 21, 991-1003. PMID: 22082830
5. Yun, J. et al. (2014) eLife 3, e01958. PMID: 24898855
Note For research use only.
Images
  • Anti-Parkin Recombinant Antibody (N136/16)

    SDS-PAGE

    SDS-PAGE for Anti-Parkin Antibody (N136/16).

  • Anti-Parkin Recombinant Antibody (N136/16)

    Immunofluorescence

    Mouse tissue section stained by immunofluorescence showing Parkin protein (green) in scattered cells, with nuclei counterstained by DAPI (blue).

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list